Regardless of outward dynamics, healthcare is one of life's necessities. It is inspiring to work alongside these businesses as they look to grow and develop and continue to support our community.
Hannah provides mergers and acquisitions (M&A) advisory services as a member of Lincoln’s Global Healthcare Group. She has executed both sell-side and buy-side M&A transactions for a range of private equity-owned and public clients, and in previous roles completed two of the largest initial public offerings on the Australian Securities Exchange and restructured a number of portfolio companies of large multinational private equity clients in Australia. Hannah’s experience spans domestic and international markets, having advised clients based in the U.S., U.K., New Zealand, Australia and parts of Asia.
Hannah applies her deep healthcare expertise to help clients with transactional opportunities as a result of positive macro trends in the industry. By running bespoke, competitive global processes with her full focus on all facets of a transaction, Hannah ensures an optimal outcome for her clients.
Prior to joining Lincoln, Hannah worked in the healthcare M&A team at KPMG. Previously, she worked in the special situations team of Moelis & Company in Sydney, focused primarily on capital restructures, capital amendments and equity conversions. Hannah started her career in the equity capital markets team at Credit Suisse.
Hannah earned a Bachelor of Laws and a Bachelor of Commerce from the University of Newcastle, Australia.
Recent Transactions in Healthcare
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical
Lincoln International is pleased to announce that Alpha Technics, a Gen Cap America portfolio company, has been sold to TE Connectivity
Lincoln International is pleased to have advised Silverfleet Capital on its agreed acquisition of CARE Fertility from Bowmark Capital
Lincoln International is pleased to announce that it advised Brenntag AG in the sale of Biosector A/S to British specialty chemicals company Croda International plc for a total consideration of Euro 72 million
Lincoln’s Healthcare and TMT groups team to create outlier result for leading Healthcare IT platform
Lincoln International represents Path-Tec, a portfolio company of Fulcrum Equity Partners, in its sale to Lab Logistics, a portfolio company of Atlantic Street Capital